TrialJournal of bone and mineral metabolism2016

Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study.

Tetsuo Nakano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.